![David Lasecki](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Lasecki
Nessuna posizione attualmente
Profilo
David Lasecki worked as a Senior Director-Oncology Sales at Heron Therapeutics, Inc. and as a Chief Commercialization Officer at GenomOncology LLC.
He also briefly worked as an Executive Director-Strategic Alliances at Cellectar Biosciences, Inc. Mr. Lasecki completed his undergraduate degree at the University of Mount Union.
Precedenti posizioni note di David Lasecki
Società | Posizione | Fine |
---|---|---|
CELLECTAR BIOSCIENCES, INC. | Corporate Officer/Principal | 01/11/2022 |
HERON THERAPEUTICS, INC. | Corporate Officer/Principal | - |
GenomOncology LLC
![]() GenomOncology LLC Packaged SoftwareTechnology Services GenomOncology LLC develops technology for genetic information. The firm provides knowledge-enabled workflows to support clinical decision making across precision medicine programs. Its tailored workflows empower clinical laboratories, medical informatics initiatives, oncologists and multi-disciplinary teams to guide patient treatment, while gaining and applying insights to optimize cancer care. The firm's products include clinical oncology, molecular pathology, cancer informatics. The company was founded by Manuel J. Glynias in 2012 and is headquartered in Cleveland, OH. | Corporate Officer/Principal | - |
Formazione di David Lasecki
University of Mount Union | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
CELLECTAR BIOSCIENCES, INC. | Health Technology |
HERON THERAPEUTICS, INC. | Health Technology |
Aziende private | 1 |
---|---|
GenomOncology LLC
![]() GenomOncology LLC Packaged SoftwareTechnology Services GenomOncology LLC develops technology for genetic information. The firm provides knowledge-enabled workflows to support clinical decision making across precision medicine programs. Its tailored workflows empower clinical laboratories, medical informatics initiatives, oncologists and multi-disciplinary teams to guide patient treatment, while gaining and applying insights to optimize cancer care. The firm's products include clinical oncology, molecular pathology, cancer informatics. The company was founded by Manuel J. Glynias in 2012 and is headquartered in Cleveland, OH. | Technology Services |
- Borsa valori
- Insiders
- David Lasecki